Literature DB >> 4596620

A double-blind clinical trial of griseofulvin in patients with Raynaud's phenomenon.

S Sabri, R F Higgins, V C Roberts, L T Cotton, D I Williams, L C Wilson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4596620      PMCID: PMC2495749          DOI: 10.1136/pgmj.49.575.641

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  8 in total

1.  [SUCCESSFUL TREATMENT OF DIFFUSE SCLERODERMA WITH GRISEOFULVIN].

Authors:  J H BOUR; G CREMER
Journal:  Ned Tijdschr Geneeskd       Date:  1963-11-16

2.  PROGNOSIS IN RAYNAUD'S PHENOMENON AFTER SYMPATHECTOMY.

Authors:  E N JOHNSTON; R SUMMERLY; M BIRNSTINGL
Journal:  Br Med J       Date:  1965-04-10

3.  The treatment of angina pectoris with griseofulvin. Preliminary communication.

Authors:  N P DEPASQUALE; J W BURKS; G E BURCH
Journal:  JAMA       Date:  1963-05-04       Impact factor: 56.272

4.  Treatment of shoulder-hand syndrome with griseofulvin.

Authors:  A COHEN; J GOLDMAN; R DANIELS; W KANENSON
Journal:  J Am Med Assoc       Date:  1960-06-04

5.  Griseofulvin in Raynaud's phenomenon.

Authors:  B R Allen
Journal:  Lancet       Date:  1971-10-16       Impact factor: 79.321

6.  Skin temperature changes in Raynaud's disease after griseofulvin.

Authors:  C R Charles; E S Carmick
Journal:  Arch Dermatol       Date:  1970-03

7.  Griseofulvin in Raynaud's disease.

Authors:  W E Hasker
Journal:  Lancet       Date:  1970-11-28       Impact factor: 79.321

8.  The effect of local application of glyceryl trinitrate (nitroglycerine) on Raynaud's disease and Raynaud's phenomenon; studies on blood flow and clinical manifestations.

Authors:  M KLECKNER; E V ALLEN; K G WAKIM
Journal:  Circulation       Date:  1951-05       Impact factor: 29.690

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.